Author

E. Perlstein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Organism:C. elegans· 1 Approach:deep learning· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

F. S. Sam· 1 shared H. Tsang· 1 shared J. D. Mast· 1 shared M. Prangley· 1 shared N. DiPrimio· 1 shared S. Iyer· 1 shared T. P. Rodriguez· 1 shared Z. M. Parton· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

F. S. Sam

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Drug screens of NGLY1 Deficiency worm and fly models reveal catecholamine, NRF2 and anti-inflammatory pathway activation as potential clinical approaches

S. Iyer, J. D. Mast, H. Tsang, T. P. Rodriguez, N. DiPrimio, M. Prangley, F. S. Sam, Z. M. Parton, E. Perlstein

The paper identifies drug candidates that rescue growth in NGLY1-deficient worm and fly models by targeting NRF2, anti-inflammatory pathways, and catecholamine signaling.

bioRxiv · Aug 28, 2019Pharmacology & Toxicology